Mostra i principali dati dell'item

dc.creatorSpanos K., Athanasoulas A., Argyriou C., Vassilopoulos I., Giannoukas A.D.en
dc.date.accessioned2023-01-31T09:59:51Z
dc.date.available2023-01-31T09:59:51Z
dc.date.issued2016
dc.identifier.issn03929590
dc.identifier.urihttp://hdl.handle.net/11615/79247
dc.description.abstractBACKGROUND: Atrial fibrillation (AF) is the commonest source of arterial embolization causing acute limb ischemia (ALI). The aim of this study was to assess the adherence of anticoagulation in AF patients and the treatment of underdiagnosed AF patients, presenting with ALI in our service and to evaluate the risk factors associated with morbidity and mortality. METHODS: A retrospective analysis of prospectively collected data was carried out from 115 limbs of 112 consecutive patients presenting with ALI of AF origin from 2008 until 2012 to a tertiary vascular service. RESULT S: The mean transfer time to hospital was 12±8.5 h. On admission, only half of the patients were aware of having AF and only 67% of those patients were receiving oral anticoagulants at the time of their admission. Nearly all patients who were on Vitamin K Antagonists (VKA) had sub-therapeutic levels preoperatively on admission (92%). The 30-day postoperative mortality and morbidity rates were 1.7% and 47% respectively. The lower limb amputation rate was 4.4% and was only associated with diabetes mellitus (DM) (P=0.009553). Reversible renal impairment was correlated with increased creatinine phosphokinase (CPK) blood levels on admission (P=0.038). CONCLUSIONS: A considerable number of patients with AF might still remain without proper anticoagulation. DM increases the risk of lower limb loss after ALI. Development of renal impairment after thromboembolectomy for ALI is more likely in the presence of elevated CPK blood levels on admission. © 2015 EDIZIONI MINER VA MEDICA.en
dc.language.isoenen
dc.sourceInternational Angiologyen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84982949231&partnerID=40&md5=c90d73303278dfb4858d91c102971c41
dc.subjectanticoagulant agenten
dc.subjectantivitamin Ken
dc.subjectcreatine kinaseen
dc.subjectlow molecular weight heparinen
dc.subjectanticoagulant agenten
dc.subjectbiological markeren
dc.subjectcreatine kinaseen
dc.subjectabdominal aorta aneurysmen
dc.subjectacute diseaseen
dc.subjectacute kidney failureen
dc.subjectadulten
dc.subjectageden
dc.subjectanticoagulant therapyen
dc.subjectArticleen
dc.subjectatrial fibrillationen
dc.subjectbrain ischemiaen
dc.subjectcerebrovascular diseaseen
dc.subjectchronic obstructive lung diseaseen
dc.subjectclinical evaluationen
dc.subjectclinical featureen
dc.subjectcoronary artery diseaseen
dc.subjectcreatine kinase blood levelen
dc.subjectdiabetes mellitusen
dc.subjectdiabetic patienten
dc.subjectdisease associationen
dc.subjectdisease durationen
dc.subjectdyslipidemiaen
dc.subjectelectrolyte disturbanceen
dc.subjectfemaleen
dc.subjectheart diseaseen
dc.subjectheparinizationen
dc.subjecthospital admissionen
dc.subjecthumanen
dc.subjecthypertensionen
dc.subjectleg amputationen
dc.subjectleg ischemiaen
dc.subjectlimb ischemiaen
dc.subjectmajor clinical studyen
dc.subjectmaleen
dc.subjectmedical historyen
dc.subjectmedication complianceen
dc.subjectmorbidityen
dc.subjectmortalityen
dc.subjectmortality risken
dc.subjectpatient complianceen
dc.subjectpatient transporten
dc.subjectperoperative complicationen
dc.subjectpostoperative complicationen
dc.subjectretrospective studyen
dc.subjectsmokingen
dc.subjectupper limben
dc.subjectvery elderlyen
dc.subjectacute diseaseen
dc.subjectadverse effectsen
dc.subjectatrial fibrillationen
dc.subjectblooden
dc.subjectcomplicationen
dc.subjectdiabetes mellitusen
dc.subjectembolectomyen
dc.subjectGreeceen
dc.subjectischemiaen
dc.subjectKidney Diseasesen
dc.subjectmiddle ageden
dc.subjectrisk factoren
dc.subjecttertiary care centeren
dc.subjectthrombectomyen
dc.subjecttime factoren
dc.subjecttreatment outcomeen
dc.subjectAcute Diseaseen
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectAnticoagulantsen
dc.subjectAtrial Fibrillationen
dc.subjectBiomarkersen
dc.subjectCreatine Kinaseen
dc.subjectDiabetes Mellitusen
dc.subjectEmbolectomyen
dc.subjectFemaleen
dc.subjectGreeceen
dc.subjectHumansen
dc.subjectIschemiaen
dc.subjectKidney Diseasesen
dc.subjectMaleen
dc.subjectMedication Adherenceen
dc.subjectMiddle Ageden
dc.subjectRetrospective Studiesen
dc.subjectRisk Factorsen
dc.subjectTertiary Care Centersen
dc.subjectThrombectomyen
dc.subjectTime Factorsen
dc.subjectTreatment Outcomeen
dc.subjectEdizioni Minerva Medicaen
dc.titleAcute limb ischemia and anticoagulation in patients with history of atrial fibrillationen
dc.typejournalArticleen


Files in questo item

FilesDimensioneFormatoMostra

Nessun files in questo item.

Questo item appare nelle seguenti collezioni

Mostra i principali dati dell'item